Burkhard Göke

727 total citations
11 papers, 550 citations indexed

About

Burkhard Göke is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Burkhard Göke has authored 11 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Burkhard Göke's work include Diabetes Treatment and Management (6 papers), Neuropeptides and Animal Physiology (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Burkhard Göke is often cited by papers focused on Diabetes Treatment and Management (6 papers), Neuropeptides and Animal Physiology (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Burkhard Göke collaborates with scholars based in Germany, Italy and United States. Burkhard Göke's co-authors include Uwe Wank, Martin Katschinski, J Schirra, R. Arnold, C. Weidmann, Theo Schäfer, Hans-Christoph Fehmann, Rüdiger Göke, P. Berghöfer and Richard G. Peterson and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Experimental Cell Research.

In The Last Decade

Burkhard Göke

11 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burkhard Göke Germany 7 409 255 129 129 102 11 550
Linda A. Jarboe United States 9 262 0.6× 255 1.0× 120 0.9× 44 0.3× 54 0.5× 10 438
Eckart Bartels Germany 2 382 0.9× 217 0.9× 137 1.1× 59 0.5× 57 0.6× 3 433
Ola Lindgren Sweden 11 504 1.2× 317 1.2× 139 1.1× 241 1.9× 135 1.3× 20 739
Annegrete Juul Denmark 4 334 0.8× 211 0.8× 113 0.9× 104 0.8× 94 0.9× 6 434
Christopher Bannon United Kingdom 5 168 0.4× 153 0.6× 97 0.8× 84 0.7× 90 0.9× 11 346
Emma K. Biggs United Kingdom 5 258 0.6× 168 0.7× 171 1.3× 129 1.0× 77 0.8× 7 454
R Lugari Italy 7 207 0.5× 140 0.5× 89 0.7× 100 0.8× 68 0.7× 14 362
Chizuko Ohboshi Japan 9 238 0.6× 177 0.7× 83 0.6× 36 0.3× 85 0.8× 14 348
Jens Pedersen Denmark 9 382 0.9× 339 1.3× 175 1.4× 178 1.4× 61 0.6× 16 599
Patricia V. Højberg Denmark 7 771 1.9× 530 2.1× 314 2.4× 117 0.9× 61 0.6× 7 885

Countries citing papers authored by Burkhard Göke

Since Specialization
Citations

This map shows the geographic impact of Burkhard Göke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Göke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Göke more than expected).

Fields of papers citing papers by Burkhard Göke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Göke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Göke. The network helps show where Burkhard Göke may publish in the future.

Co-authorship network of co-authors of Burkhard Göke

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard Göke. A scholar is included among the top collaborators of Burkhard Göke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard Göke. Burkhard Göke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lankat–Buttgereit, Brigitte, et al.. (2009). Molecular cloning of a cDNA encoding for the GLP-1 receptor expressed in rat lung. Experimental and Clinical Endocrinology & Diabetes. 102(4). 341–347. 6 indexed citations
2.
Steinhoff, Martin, et al.. (2001). Indirect RT–PCR in-situ hybridization: a novel non-radioactive method for detecting glucose-dependent insulinotropic peptide. Regulatory Peptides. 97(2-3). 187–194. 5 indexed citations
3.
Wank, Uwe, J Schirra, R. Arnold, Burkhard Göke, & Martin Katschinski. (1998). Effects of GLP-1 on proximal gastric motor and sensory function in human. Gastroenterology. 114. A1190–A1190. 4 indexed citations
4.
Berghöfer, P., et al.. (1997). Incretin hormone expression in the gut of diabetic mice and rats. Metabolism. 46(3). 261–267. 33 indexed citations
5.
Hörsch, Dieter, et al.. (1996). Galanin is a potent inhibitor of glucagon-like peptide-1 secretion from rat ileum. Peptides. 17(4). 571–576. 24 indexed citations
6.
Schirra, J, Martin Katschinski, C. Weidmann, et al.. (1996). Gastric emptying and release of incretin hormones after glucose ingestion in humans.. Journal of Clinical Investigation. 97(1). 92–103. 344 indexed citations
7.
Gherzi, Roberto, et al.. (1995). The Glucagon Gene Is Transcribed in β-like Pancreatic Cells. Experimental Cell Research. 218(2). 460–468. 5 indexed citations
8.
Fehmann, Hans-Christoph & Burkhard Göke. (1995). Characterization of GIP(1–30) and GIP(1–42) as stimulators of proinsulin gene transcription. Peptides. 16(6). 1149–1152. 39 indexed citations
9.
Göke, Rüdiger, et al.. (1994). Glycosylation of the GLP-1 receptor is a prerequisite for regular receptor function. Peptides. 15(4). 675–681. 25 indexed citations
10.
Göke, Rüdiger, et al.. (1993). Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7–36) amide on the rat pancreas. Research in Experimental Medicine. 193(1). 97–103. 64 indexed citations
11.
Göke, Burkhard, et al.. (1992). [Cloning of secretin, VIP and somatostatin receptor cDNA's].. PubMed. 30(7). 498–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026